Time to <i>Akt</i>: Superior tumor-reactive T cells for adoptive immunotherapy.

van der Waart, Anniek B; Hobo, Willemijn; Dolstra, Harry

Time to Akt: Superior tumor-reactive T cells for adoptive immunotherapy.

van der Waart, Anniek B; Hobo, Willemijn; Dolstra, Harry.

Afiliación

van der Waart AB; Department of Laboratory Medicine - Laboratory of Hematology; Radboud university medical center ; Nijmegen, The Netherlands.
Hobo W; Department of Laboratory Medicine - Laboratory of Hematology; Radboud university medical center ; Nijmegen, The Netherlands.
Dolstra H; Department of Laboratory Medicine - Laboratory of Hematology; Radboud university medical center ; Nijmegen, The Netherlands.

Oncoimmunology ; 4(5): e1003016, 2015 May.

Article en En | MEDLINE | ID: mdl-26155398

Palabras clave

ACT: adoptive cell therapy; APC: antigen-presenting cells; Akt; Allo-SCT: allogeneic stem cell transplantation; CAR: chimeric antigen receptor; DCs: dendritic cells; IL-15; IL-7; MiHAs: minor histocompatibility antigens; T-cell differentiation; TCR: T-cell receptor; TILs: tumor-infiltrating lymphocytes; Tcm: central memory T; Teff: effector T; Tem: effector memory T; Tn: naive T; Tscm: stem cell memory T; Wnt; adoptive T cell therapy; dendritic cell; stem cell transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos